Afferent Medical Solutions develops non-invasive neuromodulation devices designed for the treatment of circulatory system diseases, particularly hypertension. Their technology allows patients to self-administer therapy at home, improving health outcomes in a therapeutic area that is often inadequately addressed by existing medications.
Funding
$860K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hypertension and other circulatory system diseases are often inadequately managed by existing medications, leading to poor health outcomes. Current treatment options may not be well-tolerated or require frequent clinic visits, impacting patient compliance and quality of life.
Solution
Afferent Medical Solutions develops non-invasive neuromodulation devices designed to treat circulatory system diseases, including hypertension. Their device-based therapy allows patients to self-administer treatment from home, potentially improving health outcomes and adherence. The technology leverages scientific research in neuroscience to provide a well-tolerated alternative or adjunct to traditional pharmaceutical interventions. By targeting the nervous system's role in regulating circulatory function, Afferent aims to address the underlying causes of these conditions.
Target Audience
The primary target audience includes individuals diagnosed with hypertension and other circulatory system diseases, as well as healthcare providers seeking alternative or complementary treatment options.
Features
- Non-invasive neuromodulation technology
- Device-based therapy for self-administration at home
- Designed for the treatment of circulatory system diseases, particularly hypertension